Amwell (AMWL) has announced CFO Mark Hirschhorn will take on an expanded role as COO, effective Jan. 1, 2025. Hirschhorn will now oversee the company’s operational and growth strategies, including the clinical, sales and marketing teams, while continuing his responsibilities as CFO. Two executives will leave the company. chief commercial and growth officer Kathy Weiler, and COO Kurt Knight, will depart Amwell at the end of the year.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks